These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 27639989

  • 1. Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety.
    Vincenzi F, Ravani A, Pasquini S, Merighi S, Gessi S, Romagnoli R, Baraldi PG, Borea PA, Varani K.
    Neuropharmacology; 2016 Dec; 111():283-292. PubMed ID: 27639989
    [Abstract] [Full Text] [Related]

  • 2. TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice.
    Vincenzi F, Targa M, Romagnoli R, Merighi S, Gessi S, Baraldi PG, Borea PA, Varani K.
    Neuropharmacology; 2014 Jun; 81():6-14. PubMed ID: 24486382
    [Abstract] [Full Text] [Related]

  • 3. Adenosine A1 receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice.
    Prediger RD, Batista LC, Takahashi RN.
    Eur J Pharmacol; 2004 Sep 19; 499(1-2):147-54. PubMed ID: 15363961
    [Abstract] [Full Text] [Related]

  • 4. Activation of adenosine A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice.
    Prediger RD, da Silva GE, Batista LC, Bittencourt AL, Takahashi RN.
    Neuropsychopharmacology; 2006 Oct 19; 31(10):2210-20. PubMed ID: 16407902
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus.
    Gonçalves FQ, Pires J, Pliassova A, Beleza R, Lemos C, Marques JM, Rodrigues RJ, Canas PM, Köfalvi A, Cunha RA, Rial D.
    Eur J Neurosci; 2015 Apr 19; 41(7):878-88. PubMed ID: 25704806
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.
    Stemmelin J, Cohen C, Terranova JP, Lopez-Grancha M, Pichat P, Bergis O, Decobert M, Santucci V, Françon D, Alonso R, Stahl SM, Keane P, Avenet P, Scatton B, le Fur G, Griebel G.
    Neuropsychopharmacology; 2008 Feb 19; 33(3):574-87. PubMed ID: 17460614
    [Abstract] [Full Text] [Related]

  • 14. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
    Barbalho CA, Nunes-de-Souza RL, Canto-de-Souza A.
    Brain Res; 2009 Apr 24; 1267():65-76. PubMed ID: 19268657
    [Abstract] [Full Text] [Related]

  • 15. Adenosine A1 receptor activation modulates N-methyl-d-aspartate (NMDA) preconditioning phenotype in the brain.
    Constantino LC, Pamplona FA, Matheus FC, Ludka FK, Gomez-Soler M, Ciruela F, Boeck CR, Prediger RD, Tasca CI.
    Behav Brain Res; 2015 Apr 01; 282():103-10. PubMed ID: 25557798
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.
    Heitman LH, Mulder-Krieger T, Spanjersberg RF, von Frijtag Drabbe Künzel JK, Dalpiaz A, IJzerman AP.
    Br J Pharmacol; 2006 Mar 01; 147(5):533-41. PubMed ID: 16444290
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of 6-methoxyflavanone as a novel anxiolytic agent: A behavioral and pharmacokinetic approach.
    Akbar S, Subhan F, Karim N, Aman U, Ullah S, Shahid M, Ahmad N, Fawad K, Sewell RD.
    Eur J Pharmacol; 2017 Apr 15; 801():19-27. PubMed ID: 28257822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.